• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降钙素抑制乳腺癌细胞的侵袭:尿激酶型纤溶酶原激活剂(uPA)及uPA受体的作用

Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.

作者信息

Han Bo, Nakamura Misa, Zhou Gengyin, Ishii Aiko, Nakamura Atsushi, Bai Yanhua, Mori Ichiro, Kakudo Kennichi

机构信息

Department of Pathology, Wakayama Medical University, Wakayama 641-8509, Japan.

出版信息

Int J Oncol. 2006 Apr;28(4):807-14.

PMID:16525628
Abstract

There is a growing body of evidence indicating that calcitonin (CT) and calcitonin receptor (CTR) are involved in the regulation of cell growth, differentiation, and survival and in tissue development. However, the precise functional role of CT/CTR in breast cancer is still unknown. It is well established that the urokinase plasminogen activator (uPA) system plays an important role in breast cancer invasion and metastasis. The goal of this study was to investigate the effects of CT on regulation of the uPA system and invasive capacity of breast cancer cells. In the highly invasive MDA-MB-231 cell line, 10(-8) M CT decreased both uPA and uPAR mRNA and protein expression which was associated with inhibition of the extracellular signal-regulated kinase (ERK) 1/2 pathway. Furthermore, two weeks of CT administration to nude mice inhibited the expression of uPA mRNA in primary tumors by 25% (P<0.05), as compared to control, untreated animals. CT also inhibited the invasiveness of MDA-MB-231 cells by 37% (10(-8) M CT, P<0.05), as determined by a Matrigel invasion assay. To the best of our knowledge, this is the first report describing a direct effect of CT on breast cancer cell invasion. Our data might suggest a close link between CT signaling, the uPA-mediated pathway, and breast cancer invasion.

摘要

越来越多的证据表明,降钙素(CT)和降钙素受体(CTR)参与细胞生长、分化和存活的调节以及组织发育。然而,CT/CTR在乳腺癌中的确切功能作用仍不清楚。尿激酶型纤溶酶原激活剂(uPA)系统在乳腺癌侵袭和转移中起重要作用,这一点已得到充分证实。本研究的目的是探讨CT对uPA系统调节及乳腺癌细胞侵袭能力的影响。在高侵袭性的MDA-MB-231细胞系中,10(-8) M的CT降低了uPA和uPAR的mRNA及蛋白表达,这与细胞外信号调节激酶(ERK)1/2通路的抑制有关。此外,与未处理的对照裸鼠相比,给裸鼠连续两周注射CT可使原发肿瘤中uPA mRNA的表达降低25%(P<0.05)。通过基质胶侵袭试验测定,CT还使MDA-MB-231细胞的侵袭能力降低了37%(10(-8) M CT,P<0.05)。据我们所知,这是第一份描述CT对乳腺癌细胞侵袭有直接作用的报告。我们的数据可能提示CT信号传导、uPA介导的通路与乳腺癌侵袭之间存在密切联系。

相似文献

1
Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.降钙素抑制乳腺癌细胞的侵袭:尿激酶型纤溶酶原激活剂(uPA)及uPA受体的作用
Int J Oncol. 2006 Apr;28(4):807-14.
2
The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.乳腺肿瘤组织基质中的尿激酶系统与乳腺癌细胞侵袭
Int J Oncol. 2009 Jan;34(1):15-23.
3
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.用于测定乳腺癌患者原发肿瘤组织中尿激酶型纤溶酶原激活剂和纤溶酶原激活剂抑制剂1 mRNA的定量逆转录聚合酶链反应检测:与酶联免疫吸附测定法进行抗原定量的比较
Int J Mol Med. 2008 Feb;21(2):251-9.
4
Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system.巨噬细胞抑制细胞因子-1通过上调尿激酶型纤溶酶原激活系统诱导胃癌细胞的侵袭性。
Cancer Res. 2003 Aug 1;63(15):4648-55.
5
Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).可溶性尿激酶型纤溶酶原激活物受体(CD87)过表达可减少乳腺癌肿瘤生长及肺转移。
Cancer Gene Ther. 2000 Feb;7(2):292-9. doi: 10.1038/sj.cgt.7700144.
6
Prevention of breast cancer growth, invasion, and metastasis by antiestrogen tamoxifen alone or in combination with urokinase inhibitor B-428.抗雌激素他莫昔芬单独或与尿激酶抑制剂B-428联合使用预防乳腺癌生长、侵袭和转移。
Cancer Res. 1997 Aug 15;57(16):3585-93.
7
DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.DU145人前列腺癌的侵袭性受表皮生长因子受体(EGFR)信号下游的尿激酶受体(uPAR)调节。
Exp Cell Res. 2004 Sep 10;299(1):91-100. doi: 10.1016/j.yexcr.2004.05.008.
8
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.靶向人胰腺癌细胞中的尿激酶型纤溶酶原激活物受体可抑制c-Met和胰岛素样生长因子-I受体介导的迁移、侵袭以及小鼠原位肿瘤生长。
Cancer Res. 2005 Sep 1;65(17):7775-81. doi: 10.1158/0008-5472.CAN-05-0946.
9
Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.细胞外基质金属蛋白酶诱导剂上调尿激酶型纤溶酶原激活系统,促进肿瘤细胞侵袭。
Cancer Res. 2007 Jan 1;67(1):9-15. doi: 10.1158/0008-5472.CAN-06-2448.
10
Heregulin regulation of urokinase plasminogen activator and its receptor: human breast epithelial cell invasion.Heregulin对尿激酶型纤溶酶原激活剂及其受体的调控:人乳腺上皮细胞侵袭
Cancer Res. 2001 Jan 1;61(1):400-5.

引用本文的文献

1
A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells.一种姜黄素类似物CA-5f可抑制尿激酶型纤溶酶原激活物及三阴性乳腺癌细胞的侵袭表型。
Toxicol Res. 2021 Nov 17;38(1):19-26. doi: 10.1007/s43188-021-00112-2. eCollection 2022 Jan.
2
The Epithelial-Myeloid-Transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for Epithelial- Mesenchymal-Transition hypothesis (EMT)?癌细胞的上皮-髓样转化(EMyeT)作为一种被错误认知的原发性炎症过程,最终发展为骨重塑恶性肿瘤:上皮-间质转化假说(EMT)的替代途径?
J Cancer. 2019 Jun 9;10(16):3798-3809. doi: 10.7150/jca.31364. eCollection 2019.
3
Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas.降钙素受体家族在原发性人高级别脑胶质瘤样本中的表达和活性。
BMC Cancer. 2019 Feb 18;19(1):157. doi: 10.1186/s12885-019-5369-y.
4
Metastatic and triple-negative breast cancer: challenges and treatment options.转移性和三阴性乳腺癌:挑战与治疗选择。
Drug Deliv Transl Res. 2018 Oct;8(5):1483-1507. doi: 10.1007/s13346-018-0551-3.
5
Calcitonin receptor expression in medullary thyroid carcinoma.降钙素受体在甲状腺髓样癌中的表达。
PeerJ. 2017 Sep 13;5:e3778. doi: 10.7717/peerj.3778. eCollection 2017.
6
Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells.降钙素通过肾小管细胞中的ERK1/2信号通路诱导结缔组织生长因子。
Exp Mol Med. 2009 May 31;41(5):307-15. doi: 10.3858/emm.2009.41.5.034.
7
RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.RNA干扰介导靶向IOMM-lee恶性脑膜瘤细胞系中的尿激酶型纤溶酶原激活物受体和基质金属蛋白酶-9基因表达可抑制肿瘤生长、肿瘤细胞侵袭和血管生成。
Int J Oncol. 2007 Jul;31(1):5-17.